Cas:81263-97-0 ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester manufacturer & supplier

Chemical Name:ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester

CAS.NO:81263-97-0

Synonyms:1-O-[(5β,6β,8α,9β,10α,11β,13α)-6,11-Dihydroxy-15,18-dioxokaur-16-en-18-yl]-β-D-glucopyranose;1-O-[(5β,8α,9β,10α)-6,11-Dihydroxy-15,18-dioxokaur-16-en-18-yl]-β-D-glucopyranose

Molecular Formula:C₂₆H₃₈O₁₀

Molecular Weight:510.574

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:713.4±60.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.624

PSA:173.98000

Exact Mass:510.246490

LogP:0.06

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-O-[(5β,6β,8α,9β,10α,11β,13α)-6,11-Dihydroxy-15,18-dioxokaur-16-en-18-yl]-β-D-glucopyranose chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-O-[(5β,8α,9β,10α)-6,11-Dihydroxy-15,18-dioxokaur-16-en-18-yl]-β-D-glucopyranose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-O-[(5β,8α,9β,10α)-6,11-Dihydroxy-15,18-dioxokaur-16-en-18-yl]-β-D-glucopyranose Use and application,1-O-[(5β,8α,9β,10α)-6,11-Dihydroxy-15,18-dioxokaur-16-en-18-yl]-β-D-glucopyranose technical grade,usp/ep/jp grade.

Related News: The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester manufacturer As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester supplier Under the strict supervision of environmental protection, it has helped the API industry to continuously optimize its product structure, realize industrial upgrading, and transition to the development of high-end APIs. ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester factory The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter.